These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6126197)

  • 21. Effects of peripheral sympathetic blockade with dapiprazole on the fear-inhibited light reflex.
    Giakoumaki SG; Hourdaki E; Grinakis V; Theou K; Bitsios P
    J Psychopharmacol; 2005 Mar; 19(2):139-48. PubMed ID: 15728435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
    Bartoszyk GD; Harting J; Minck KO
    J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia.
    Park WK; Jeong D; Cho H; Lee SJ; Cha MY; Pae AN; Choi KI; Koh HY; Kong JY
    Pharmacol Biochem Behav; 2005 Oct; 82(2):361-72. PubMed ID: 16216322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.
    Khisti RT; Deshpande LS; Chopde CT
    Psychopharmacology (Berl); 2002 May; 161(2):120-8. PubMed ID: 11981591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity.
    Marquis KL; Sabb AL; Logue SF; Brennan JA; Piesla MJ; Comery TA; Grauer SM; Ashby CR; Nguyen HQ; Dawson LA; Barrett JE; Stack G; Meltzer HY; Harrison BL; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 2007 Jan; 320(1):486-96. PubMed ID: 17038512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychopharmacological studies on (--)-nuciferine and its Hofmann degradation product atherosperminine.
    Bhattacharya SK; Bose R; Ghosh P; Tripathi VJ; Ray AB; Dasgupta B
    Psychopharmacology (Berl); 1978 Sep; 59(1):29-33. PubMed ID: 100809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
    J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal exposure to cocaine reduces dopaminergic D1-mediated motor function but spares the enhancement of learning by amphetamine in rabbits.
    Simansky KJ; Baker G; Kachelries WJ; Hood H; Romano AG; Harvey JA
    Ann N Y Acad Sci; 1998 Jun; 846():375-8. PubMed ID: 9668429
    [No Abstract]   [Full Text] [Related]  

  • 29. [Neuroleptic-like activity of the tripeptide neurotensin analog GZR-123].
    Guzevatykh LS; Ostrovskaia RU; Gudasheva TA; Zaĭtseva NI; Voronina TA
    Eksp Klin Farmakol; 2002; 65(1):3-6. PubMed ID: 12025780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of muscarinic receptor agonists on animal models of psychosis.
    Karan RS; Ravishankar P; Pandhi P
    Methods Find Exp Clin Pharmacol; 2000 Apr; 22(3):169-72. PubMed ID: 10893700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral pharmacology of the benzamides as compared to standard neuroleptics.
    Worms P
    Adv Biochem Psychopharmacol; 1982; 35():7-16. PubMed ID: 6128876
    [No Abstract]   [Full Text] [Related]  

  • 33. Psychotropic actions of clonidine.
    Lal H; Shearman GT
    Prog Clin Biol Res; 1981; 71():99-145. PubMed ID: 6276904
    [No Abstract]   [Full Text] [Related]  

  • 34. Cinnarizine has an atypical antipsychotic profile in animal models of psychosis.
    Dall'Igna OP; Tort AB; Souza DO; Lara DR
    J Psychopharmacol; 2005 Jul; 19(4):342-6. PubMed ID: 15982988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of opiate withdrawal and cocaine hyperarousal syndromes by buspirone. Possible pharmacotherapeutic applications.
    Aceto MD; Bowman ER
    Arzneimittelforschung; 1993 Sep; 43(9):942-5. PubMed ID: 8240454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacologic studies on the effect of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) on the vegetative and central nervous system].
    Rostock A; Hoffmann W; Ploen U; Bartsch R
    Pharmazie; 1985 Dec; 40(12):875-8. PubMed ID: 3841610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonidine: new research in psychotropic drug pharmacology.
    Fielding S; Lal H
    Med Res Rev; 1981; 1(1):97-123. PubMed ID: 7050562
    [No Abstract]   [Full Text] [Related]  

  • 38. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests.
    Bristow LJ; Collinson N; Cook GP; Curtis N; Freedman SB; Kulagowski JJ; Leeson PD; Patel S; Ragan CI; Ridgill M; Saywell KL; Tricklebank MD
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1256-63. PubMed ID: 9400001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
    Izzo E; Sanna PP; Koob GF
    Pharmacol Biochem Behav; 2005 Aug; 81(4):701-8. PubMed ID: 16005056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity: comparison with typical and atypical conventional antipsychotics.
    Bardin L; Auclair A; Kleven MS; Prinssen EP; Koek W; Newman-Tancredi A; Depoortère R
    Behav Pharmacol; 2007 Mar; 18(2):103-18. PubMed ID: 17351418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.